Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts
(Pfizer) Jan 23, 2020 - Pfizer will become the first company to bring three oncology monoclonal antibody (mAb) biosimilar treatments to the U.S. market. Read Corporate Press Release